Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 186 questions Show Answers
To ask the Scottish Government what estimate it has made of the annual cost of providing semaglutide (Wegovy) and tirzepatide (Mounjaro) treatment for reducing weight in adults under the approved NHS Scotland Patient Access Scheme, and over what timescale it expects all eligible patients to be able to access treatment.
To ask the Scottish Government, in light of NHS boards being expected to fund hybrid closed-loop (HCL) systems for eligible patients in line with NICE and SIGN guidance, what steps it will take to ensure equitable access to HCL across Scotland, and whether it will establish national targets and timelines for their continued roll-out.
To ask the Scottish Government what information it holds on the number of people on waiting lists for hybrid closed-loop (HCL) insulin pumps and the number of planned new-start patients in 2026, broken down by NHS board.
To ask the Scottish Government, in light of the Scottish Medicines Consortium's decision in June 2026 to approve the use of semaglutide (Wegovy) to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight, what discussions it has had with NHS boards regarding implementation.
To ask the Scottish Government how it plans to address any gaps in data in order to improve reporting against the National Indicators.
To ask the Scottish Government whether it will provide details of its approach and timeline for the development of the National Indicators that underpin the National Outcomes, and how it plans to consult with relevant sectors and organisations as part of this process.
To ask the Scottish Government what progress has been made in reviewing the National Performance Framework, including when the revised framework and National Outcomes will be published.
To ask the Scottish Government whether the Programme for Government 2026-27 will be closely aligned or mapped to the revised National Performance Framework.
To ask the Scottish Government whether it will consider routinely publishing national data on the number of people on waiting lists for hybrid closed-loop (HCL) insulin pumps and the number of new-start patients, to support transparency and identify any regional variation.
To ask the Scottish Government how many new-start patients are planned to commence treatment with hybrid closed-loop (HCL) insulin pump systems in 2026, and how this compares with the number of new-start patients in 2024 and 2025.